Bixiao Zhao

Bixiao Zhao

Auto-generated profile, based on publicly available information

Bixiao Zhao

Department of Surgery, Lahey Hospital and Medical Center, Burlington, Massachusetts

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2011 in Science
Verified
Journal Article
Closed access
PDF file
MCMurim Choi
Murim Choi
USUte I. Scholl
Ute I. Scholl
PYPeng Yue
Peng Yue
PBPeyman Björklund
Peyman Björklund
BZBixiao Zhao
Bixiao Zhao
RLRichard P. Lifton
Richard P. Lifton
Endocrine tumors such as aldosterone-producing adrenal adenomas (APAs), a cause of severe hypertension, feature constitutive hormone production and unrestrained cell proliferation; the mechanisms linking these events are unknown. We identify two recurrent somatic mutations in and near the selectivity filter of the potassium (K+) channel KCNJ5 that are present in 8 of 22 human APAs studied. Both produce increased sodium (Na+) conductance and cell depolarization, which in adrenal glomerulosa cells produces calcium (Ca2+) entry, the signal for aldosterone production and cell proliferation. Similarly, we identify an inherited KCNJ5 mutation that produces increased Na+ conductance in a Mendelian form of severe aldosteronism and massive bilateral adrenal hyperplasia. These findings explain pathogenesis in a subset of patients with severe hypertension and implicate loss of K+ channel selectivity in constitutive cell proliferation and hormone production.

1 August 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
RARonja Adam
Ronja Adam
ISIsabel Spier
Isabel Spier
BZBixiao Zhao
Bixiao Zhao
MKMichael Kloth
Michael Kloth
JMJonathan Marquez
Jonathan Marquez
SAStefan Aretz
Stefan Aretz

1 July 2009 in Molecular Cell
Verified
Journal Article
Closed access
LSLee R. Swem
Lee R. Swem
DSDanielle L. Swem
Danielle L. Swem
COColleen T. O'Loughlin
Colleen T. O'Loughlin
RGRaleene Gatmaitan
Raleene Gatmaitan
BZBixiao Zhao
Bixiao Zhao
BBBonnie Bassler
Bonnie Bassler

8 February 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ZZZi-Ming Zhao
Zi-Ming Zhao
BZBixiao Zhao
Bixiao Zhao
YBYalai Bai
Yalai Bai
AIAtila Iamarino
Atila Iamarino
SGStephen G. Gaffney
Stephen G. Gaffney
Jeffrey P TownsendJeffrey P Townsend
Jeffrey P Townsend
Significance: The knowledge that cancer is an evolutionary process is old, but only recently can sequencing technology provide data for clinically relevant evolutionary analyses of cancer. Approaches developed for evolutionary biology can reveal the relationship among clonal lineages, the ancestral states of gene sequences, and the timing of evolutionary events. We performed whole exome sequencing of cancer tissues from multiple sites of dozens of subjects, demonstrating nonlinear patterns of tumor progression and early origins of metastatic lineages and quantifying the times of occurrence of driver mutations. These findings direct research attention away from the search for genes that induce metastasis toward genes that are mutated early in tumorigenesis, providing therapeutic targets effective against both primary tumors and metastases.

20 December 2014 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
ISIsabel Spier
Isabel Spier
SHStefanie Holzapfel
Stefanie Holzapfel
JAJanine Altmüller
Janine Altmüller
BZBixiao Zhao
Bixiao Zhao
SHSukanya Horpaopan
Sukanya Horpaopan
SAStefan Aretz
Stefan Aretz
In a number of families with colorectal adenomatous polyposis or suspected Lynch syndrome/HNPCC, no germline alteration in the APC, MUTYH, or mismatch repair (MMR) genes are found. Missense mutations in the polymerase genes POLE and POLD1 have recently been identified as rare cause of multiple colorectal adenomas and carcinomas, a condition termed polymerase proofreading‐associated polyposis (PPAP). The aim of the present study was to evaluate the clinical relevance and phenotypic spectrum of polymerase germline mutations. Therefore, targeted sequencing of the polymerase genes POLD1, POLD2, POLD3, POLD4, POLE, POLE2, POLE3 and POLE4 was performed in 266 unrelated patients with polyposis or fulfilled Amsterdam criteria. The POLE mutation c.1270C>G;p.Leu424Val was detected in four unrelated patients. The mutation was present in 1.5% (4/266) of all patients, 4% (3/77) of all familial cases and 7% (2/30) of familial polyposis cases. The colorectal phenotype in 14 affected individuals ranged from typical adenomatous polyposis to a HNPCC phenotype, with high intrafamilial variability. Multiple colorectal carcinomas and duodenal adenomas were common, and one case of duodenal carcinoma was reported. Additionally, various extraintestinal lesions were evident. Nine further putative pathogenic variants were identified. The most promising was c.1306C>T;p.Pro436Ser in POLE. In conclusion, a PPAP was identified in a substantial number of polyposis and familial colorectal cancer patients. Screening for polymerase proofreading mutations should therefore be considered, particularly in unexplained familial cases. The present study broadens the phenotypic spectrum of PPAP to duodenal adenomas and carcinomas, and identified novel, potentially pathogenic variants in four polymerase genes.

27 November 2015 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
ISIsabel Spier
Isabel Spier
DDDmitriy Drichel
Dmitriy Drichel
MKMartin Kerick
Martin Kerick
JKJutta Kirfel
Jutta Kirfel
SHSukanya Horpaopan
Sukanya Horpaopan
SAStefan Aretz
Stefan Aretz
Background: In 30–50% of patients with colorectal adenomatous polyposis, no germline mutation in the known genes APC, causing familial adenomatous polyposis, MUTYH, causing MUTYH-associated polyposis, or POLE or POLD1, causing polymerase-proofreading-associated polyposis can be identified, although a hereditary aetiology is likely. This study aimed to explore the impact of APC mutational mosaicism in unexplained polyposis. Methods: To comprehensively screen for somatic low-level APC mosaicism, high-coverage next-generation sequencing of the APC gene was performed using DNA from leucocytes and a total of 53 colorectal tumours from 20 unrelated patients with unexplained sporadic adenomatous polyposis. APC mosaicism was assumed if the same loss-of-function APC mutation was present in ≥2 anatomically separated colorectal adenomas/carcinomas per patient. All mutations were validated using diverse methods. Results: In 25% (5/20) of patients, somatic mosaicism of a pathogenic APC mutation was identified as underlying cause of the disease. In 2/5 cases, the mosaic level in leucocyte DNA was slightly below the sensitivity threshold of Sanger sequencing; while in 3/5 cases, the allelic fraction was either very low (0.1–1%) or no mutations were detectable. The majority of mosaic mutations were located outside the somatic mutation cluster region of the gene. Conclusions: The present data indicate a high prevalence of pathogenic mosaic APC mutations below the detection thresholds of routine diagnostics in adenomatous polyposis, even if high-coverage sequencing of leucocyte DNA alone is taken into account. This has important implications for both routine work-up and strategies to identify new causative genes in this patient group.